Cutaneous larva migrans acquired in England [5]

Clinical and Experimental Dermatology

Volumn 28, Issue 6, 2003, Pages 671-672

  Patterson, C R S ^a   Kersey, P J W ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; TIABENDAZOLE;

ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DOMESTIC ANIMAL; DRUG EFFECT; DRUG FORMULATION; DRUG POTENCY; FAMILY HISTORY; HUMAN; LARVA MIGRANS; LETTER; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DISEASE; TREATMENT OUTCOME; UNITED KINGDOM;

ANIMALS; ANIMALS, DOMESTIC; ANTINEMATODAL AGENTS; CHILD; DOG DISEASES; DOGS; ENGLAND; FOOT DERMATOSES; HUMANS; LARVA MIGRANS; MALE; THIABENDAZOLE;

EID: 0242406963     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01347.x     Document Type: Letter

References (4)

1. Roest MAB, Ratnavel R. Cutaneous larva migrans contracted in England: a reminder. Clin Exp Dermatol 2001; 26: 389-90.
2. Beattie PE, Fleming CJ. Cutaneous Larva Migrans in the West of Scotland. Clin Exp Dermatol 2002; 27: 248-9.
3. Klose C, Mravak S, Geb M et al. Autochthonous cutaneous larva migrans in Germany. Trop Med Int Health 1996; 1: 503-4.
4. Zimmerman R, Combemale P, Piens MA et al. Cutaneous larva migrans, autochthonous in France. Apropos of a case. Ann Dermatol Venereol 1995; 122: 711-4.